Agilent Technologies reports strong end to 2017 fiscal year

Agilent Technologies has announced its financial results for the fourth quarter of 2017, during which it generated a revenue total of $1.19 billion (896.17 million pounds).

This represents a year-on-year increase of 7.1 percent, or 5.8 percent in core revenue terms. This exceeded the 3.5 percent figure that marked the midpoint of the company's guidance range.

The firm's life sciences and applied markets group accounted for the largest share of the company's sales, with its CrossLab and diagnostics and genomics groups also contributing positively after seeing improved performances.

For the full year ending on October 31st 2017, the company reached a $4.47 billion revenue total, up by six percent on its performance for the 2016 fiscal year. Looking ahead to 2018, a sales total in the range of $4.72 billion to $4.74 billion is expected.

Mike McMullen, Agilent's chief executive officer and president, said: "Our consistently excellent financial performance demonstrates our sustained ability to win in the marketplace, while also driving operational improvements."

With over 20 years of experience within the science market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current science roles we have available, you can search for the latest job roles, register your details, or contact the team today.